Lisa LeCointe-Cephas - 01 May 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: SVP Chief Ethics & Com Officer
Signature: /s/ Kelly E. W. Grez as attorney-in-fact for Lisa LeCointe-Cephas
Issuer symbol: MRK
Transactions as of: 01 May 2023
Net transactions value: +$48,728
Form type: 4
Filing time: 03 May 2023, 15:11:30 UTC
Previous filing: 05 May 2022
Next filing: 04 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRK	Common Stock	Options Exercise	$74,247	+643	+17%	$115.47	4,376	01 May 2023	Direct
transaction	MRK	Common Stock	Tax liability	$25,519	-221	-5.1%	$115.47	4,155	01 May 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Restricted Stock Unit	Options Exercise	$0	-643	-100%	$0.000000^*	0	01 May 2023	Common Stock	643		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Holdings include shares acquired in dividend reinvestment transactions.
F2	Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3	These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.